• Accueil >
  • Publications >
  • Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome

4 mai 2018OncoImmunology

DOI : 10.1080/2162402x.2017.1423184

Auteurs

Véronique M. Braud, Jérôme Biton, Etienne Becht, Samantha Knockaert, Audrey Mansuet-Lupo, Estelle Cosson, Diane Damotte, Marco Alifano, Pierre Validire, Fabienne Anjuère, Isabelle Cremer, Nicolas Girard, Dominique Gossot, Agathe Seguin-Givelet, Marie-Caroline Dieu-Nosjean, Claire Germain